Eli Lilly Presses Card Companies and Processors to Cut Off Retatrutide Sellers
Eli Lilly's six retatrutide lawsuits came with a call for card companies and processors to cut off sellers, and a CBS News investigation then found more than 80 businesses promoting the unapproved drug under LegitScript's seal, raising the bar for licensed telehealth and compounding merchants in underwriting.